XGN Stock Analysis: Buy, Sell, or Hold?

XGN - Exagen Inc. Common Stock

SERVICES-MEDICAL LABORATORIES
$3.68
-0.27 (-6.84%) ▼
WAIT
LOW Confidence
Protect Your XGN Gains
Last Updated: January 30, 2026
Earnings: Mar 10, 2026

Get Alerted When XGN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
⏸️ WAIT FOR STABILIZATION: XGN is down 20.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

In-depth Analysis How we analyze

Valuation Analysis: XGN is currently trading at $3.68, which is considered oversold relative to its 30-day fair value range of $4.52 to $6.22.

Technical Outlook: Technically, XGN is in a strong downtrend. The price is currently testing key support at $3.84. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.8% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.71 (+272.5%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $4.52 - $6.22
Company Quality Score 47/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 77.4%

Protect Your Profits

Holding XGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-6.8%)
  • BULLISH: Trading 272.5% below Wall St target ($14.71)
  • WARNING: Recommendation downgraded due to -20.0% 5-day decline - wait for stabilization

Fair Price Analysis

30-Day Fair Range $4.52 - $6.22
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $3.84
Resistance Level $5.05
Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) -9.97
Wall Street Target $14.71 (+272.5%)
Revenue Growth (YoY) 37.9%
Profit Margin -29.9%
Last updated: January 30, 2026 5:43 PM ET
Data refreshes hourly during market hours. Next update: 6:43 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
John Aballi SELL 31787 shares 2025-10-16

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
TMO
Thermo Fisher Scientific…
STRONG BUY
31 analysts
$653 47 HOLD
EXAS
EXACT Sciences Corporati…
STRONG BUY
26 analysts
$106 57 HOLD
GH
Guardant Health Inc
STRONG BUY
24 analysts
$121 62 BUY
DHR
Danaher Corporation
STRONG BUY
26 analysts
$263 47 HOLD
NTRA
Natera Inc
STRONG BUY
21 analysts
$257 58 HOLD

Advanced XGN Option Strategies

Professional options setups generated by AI based on today's XGN price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for XGN

XGN Technical Chart XGN Price Prediction XGN Earnings Date XGN Investment Advisor XGN Fair Price Analyzer XGN Options Advisor XGN Options Chain XGN Options Analysis XGN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals